SION Sionna Therapeutics, Inc.
Company Analysis
Latest News
🔴 Sionna Therapeutics is trading 5% down
Sionna Therapeutics is trading at $3.60, down 5.26%; no company-specific announcement explaining the October 23 decline was identified. - Sionna’s latest...
🔴 Sionna Therapeutics is trading 5% down on October 22, 2026, amid broader market weakness
Sionna Therapeutics is trading at $3.66, down 5.43%, amid broad market weakness; no company-specific catalyst was identified. - No company-specific...
🔴 Sionna Therapeutics is trading 5.78% down; no new company-specific catalyst identified
Sionna Therapeutics is trading at $3.91, down 5.78% during the October 21 session, with no new company-specific announcement identified to explain the...
🟢 Sionna Therapeutics is trading 6% up today amid broader biotech strength
Sionna Therapeutics is trading at $4.24, up 5.61%, alongside broader biotech strength, with XBI up 2.09%. - On October 20, 2026, no new company-specific...
🟢 Sionna Therapeutics is trading 5% up today amid biotech-sector strength
Sionna Therapeutics is trading 5.4% higher at $4.10 on October 19, 2026, in a move that appears consistent with biotech-sector strength. - The supplied sector...
🔴 Sionna Therapeutics is trading 5% down with no identified catalyst
Sionna Therapeutics is trading 5.39% down at $3.86; no clear company-specific announcement on October 16 explains the move. - Recent coverage revisits the...
🔴 Sionna Therapeutics is trading 5% down today amid inflation-driven market pressure
Sionna Therapeutics is trading 5.02% down now at $4.16, likely weighed down by broader market pressure after September inflation exceeded forecasts. - Higher...
🔴 Sionna Therapeutics is trading 5% down amid biotech-sector weakness
Sionna Therapeutics is trading 5.12% down at $4.45, with biotech-sector weakness a possible contributor. - No new company-specific announcement explaining the...
🔴 Sionna Therapeutics is trading 5% down in pre-market
Sionna Therapeutics is trading 5.30% lower at $4.64 in pre-market, with no clear October 12 company-specific catalyst identified. - Its latest update, dated...
🟢 Sionna Therapeutics is trading 5% up in pre-market
Sionna Therapeutics is trading at $5.15, up 5.10%, with no company-specific announcement identified to explain the October 12 pre-market move. - Its latest...
🔴 Sionna Therapeutics is trading 5.8% down in pre-market
Sionna Therapeutics is trading at $4.54, down 5.81% in pre-market, with no fresh company-specific announcement or clear catalyst identified for the October 8...
🔴 Sionna Therapeutics is trading 5.6% down amid biotech ETF weakness
Sionna Therapeutics is trading 5.6% lower at $4.58 on October 6, 2026, with biotech-sector weakness potentially weighing on the shares. - Biotech ETF XBI is...
🔴 Sionna Therapeutics is trading 6.35% down today as rising Treasury yields pressure growth assets
Sionna Therapeutics is trading at $5.16, down 6.35%, amid a broader risk-off session and pressure on growth-oriented assets from rising Treasury yields near a...
🔴 Sionna Therapeutics is trading 10% down today as U.S. equities faced broader risk-off pressure
Sionna Therapeutics is trading 10% down at $5.41 as broader risk-off conditions pressured U.S. equities on September 23, 2026. - Biotech stocks were rising, so...
🔴 Sionna Therapeutics is trading 5% down today amid possible reassessment of disappointing cystic-fibrosis results
Sionna Therapeutics is trading 5% lower at $5.71 after opening-market weakness on September 23, 2026, amid broader risk-off pressure on equities. - The Nasdaq...
🟢 Sionna Therapeutics is trading 5.37% up in pre-market amid broader risk-on sentiment
Sionna Therapeutics is trading at $6.28, up +5.37% in pre-market on September 21, 2026, apparently alongside broader risk-on sentiment rather than a newly...
🔴 Sionna Therapeutics is trading 10.3% down today; no clear company-specific catalyst identified
Sionna Therapeutics is trading 10.3% down at $6.44, with no clear company-specific catalyst identified for September 18, 2026. - Recent pressure likely...
🔴 Sionna Therapeutics is trading 5.1% down today with no clear immediate catalyst identified
Sionna Therapeutics is trading 5.1% down at $6.82, with no fresh company-specific announcement identified for September 18, 2026; the immediate decline’s...
🟢 Sionna Therapeutics is trading 5.5% up in pre-market as XBI rises
Sionna Therapeutics is trading 5.53% up now at $7.58 in pre-market, with broader biotechnology strength the apparent driver. - No fresh company-specific...
🟢 Sionna Therapeutics is trading 6.39% up today as biotech stocks rally
Sionna Therapeutics is trading 6.39% up at $7.49, supported primarily by stronger risk appetite as major U.S. indexes rise and biotechnology stocks rally. -...